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A commercially available ﬁbrinogen standard calibrated by a
World Health Organization (WHO) reference material is
widely used in Japan, and most clinical laboratories use the
Clauss method for plasma ﬁbrinogen measurement. However,
a current issue in ﬁbrinogen measurement is poor laboratory-to-
laboratory variability. To improve the reliability of ﬁbrinogen
values and thereby solve the poor precision and accuracy of plasma
ﬁbrinogen testing, the present paper develops a simple and large
preparation procedure for a suitable ﬁbrinogen standard and
quality control material and evaluates their basic performance.
With a new procedure getting high puriﬁed ﬁbrinogen by glycine
precipitation, the calibrator determined by both the Clauss and
Jacobson methods produced a ﬁbrinogen concentration of 2.20
gl
1. The total precision of the calibrator was excellent (coeﬃ-
cient of variation 1.4–2.1%) in comparison with current plasma
ﬁbrinogen materials from the WHO (#98/612) and with a
commercial standard (CV 1.9–3.9%). The within-run precision
of the calibrator on the coagulation analysers was 1.7–2.8%.
Within-analyser variability among the ﬁve instruments had good
consistency (mean 2.200.022gl
1; CV 1.0%). The degrada-
tion study of the calibrator suggested that storage at 9C for two
years was as predicted. In conclusion, the results show that the
calibrator prepared herein can be useful as a candidate Japanese
ﬁbrinogen standard and is applicable to automated and semi-
automated coagulation analysers. Additionally, it is expected
that it will be widely used in Japan by diagnostic manufacturers
and clinical laboratories as a recommended secondary standard
to estimate a ﬁbrinogen value according to the WHO primary
standard.
Introduction
Fibrinogen is a heterogeneous glycoprotein of molecular
weight 280 000–340 000 with three pairs of polypeptide
chains (A,B , ) [1]. Plasma ﬁbrinogen measurement
is a popular coagulation test and many laboratories in
Japan use Clauss’s method for the measurement. In 1992,
the ﬁrst International Fibrinogen Standard [2] was
introduced by the UK National Institute for Biological
Standards and Control (NIBSC) and it is widely used in
many laboratories. However, the current issue of ﬁbrino-
gen measurement is the poor precision that has been
reported by the Japan National External Quality Assur-
ance Surveillance [3], and the accuracy and precision of
the annual results reported by the Japanese Medical
Association (JMA) surveys conducted over the past ten
years are not improved [4]. Recently, the Hematology
Subcommittee of the Standardization Committee of the
Japan Society of Laboratory Medicine (JSLM) docu-
mented a standardized method of ﬁbrinogen measure-
ment in plasma and established a reliable ﬁbrinogen
standard for both the Clauss method and turbidimetric
immunoassay [5,6]. Therefore, the Japanese national
ﬁbrinogen standard (calibrator) was prepared for the
purpose [7] and the authors’ clinical trials were reported
[8,9]. The aim of the present paper was to demonstrate
the commutability and precision among coagulation
analysers for the calibrator of the standardization of
plasma ﬁbrinogen measurement.
Experimental
Chemical reagent
The following reagents were used: glycine, ethanol,
Tween 80 and Tri-n-butyl phosphate (TNBP) (Kishida
Chemical, Inc, Osaka, Japan), unfractionated heparin
(Aventis Pharma, Tokyo, Japan), and lysine-Sepharose
CL-6B (Amersham Pharmacia Biotec, Tokyo, Japan).
Other reagents used were of general grade.
Preparation of ﬁbrinogen standard
A ﬁbrinogen standard material was prepared from fresh
human plasma (Alpha Therapeutic Corporation, LA,
USA) according to a previous method [7]. In brief,
Cohn fraction I [10] was suspended in 55mM citrate
buﬀer, pH 6.4, containing 100mmoll
 1 NaCl and
12Uml
 1 unfractionated heparin in an ice bath, and
then centrifuged. The supernatant was treated by a
solvent detergent of 1% (v/v) Tween 80 and 0.3% (v/
v) TNBP for virus inactivation [11]. Glycine (1.8moll
 1)
was then added to the treated solution and centrifuged.
This process was repeated twice and the ﬁnal precipi-
tates collected. Precipitated ﬁbrinogen was dissolved in
20mmoll
 1 citrate buﬀer, pH 6.8, containing 100mmoll
 1
NaCl and passed through a lysine-Sepharose column
(2.5 15cm, 50ml) to remove plasminogen (ﬁgure 1).
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103The test preparation was prepared from the puriﬁed
ﬁbrinogen to a concentration of 2.20gl
 1 in a matrix of
20gl 1 protease-free bovine serum albumin (Serologicals
Corporation, GA, USA) in 20mmoll
 1 citrate buﬀer,
pH 6.8, containing 100mmoll
 1 sodium chloride. It was
then dispensed into silicone-coated glass vials, frozen and
lyophilized.
Reference material
The materials used for calibration, both prepared from
human plasma, were the World Health Organization
(WHO) ﬁbrinogen international standard (#98/612)
(NIBSC, Potters Bar, UK) [12] and the commercial
ﬁbrinogen standard (Fib standard
TM, Sysmex Corpora-
tion, Kobe, Japan). Each vial was reconstituted carefully
according to the handling instructions.
Fibrinogen measurement
The calibrators were diluted to ﬁve calibration con-
centrations (1/5, 1/10, 1/15, 1/20, 1/30 dilutions) using
Owren’s veronal buﬀer. The calibration assay of the
thrombin-clottable rate originally described by Clauss
[13] was conducted according to National Committee
for Clinical Laboratory Standards (NCCLS) procedures
[14] using a Thrombocheck Fib(L) (Sysmex) [15].
The CA-1500, CA-7000 (Sysmex), Coagrex-700 and
Coagrex-800 (Shimadzu Corporation, Kyoto, Japan)
[16] for a fully automated coagulation analyser, and
KC-4a micro (Amelung GmbH, Lemgo, Germany) for
a semi-automated coagulation analyser were used. The
clottable ﬁbrinogen concentration was determined by
Jacobsson’s method [17] using a UV-160 spectrophot-
ometer (Shimadzu).
Precision comparison between commercial materials
and the test preparation
The within-run (n¼20) and between-day (n¼5) preci-
sions in commercial ﬁbrinogen standard materials, the
WHO standard (#98/612), the Fib standard
TM and the
test preparation were examined on Coagrex-800.
Precision comparison among coagulation analysers
The within-run precision (n¼20) of the test preparation
was examined on ﬁve kinds of coagulation analysers
(Coagrex-700, Coagrex-800, CA-1500, CA-7000, KC-4a
micro) using the Clauss and Jacobsson methods.
Degradation study
The accelerated stability test of the test preparation was
examined after 0, 1, 2, 4 and 6 months of storage at  20,
4, 20, 37 and 45 C using the Coagrex-800 automated
coagulation analyser. Five vials stored at each tem-
perature were evaluated by the Clauss method. The
long-term stability was predicted using the Arrehenius
equation [18].
Statistics
A Mann–Whitney U-test was used for comparison.
Results
Precision comparison between commercial materials and
the test preparation
The coeﬃcient of variations (CVs) for within-run
(n¼20) and between-day (n¼5) precisions of the WHO
standard (#98/612), Fib standard
TM and test prepara-
tion were 1.9–3.6, 2.7–3.9 and 1.4–2.1%, respectively
(table 1).
Parallel calibration curves for the WHO standard
(#98/612) and the test preparation are shown in ﬁgure 2.
Precision comparison among coagulation analyses
The CVs for within-run (n¼20) of the test preparation
using Coagrex-700, Coagrex-800, CA-1500, CA-7000
and KC4a micro were 1.72, 2.43, 2.35, 2.71 and
2.71%, respectively (table 2), while the CV determined
by the Jacobsson method was 4.37%. The statistical
mean (gl
 1) between instruments showed no signiﬁcant
diﬀerence versus the Jacobsson method by the U–test.
The CV of between-analyser precision (ﬁve instruments)
for the test preparation was 1.00% (table 3).
Comparison of the ﬁbrinogen concentration measured
by the Clauss and Jacobsson methods
No signiﬁcant diﬀerence of ﬁbrinogen concentration
between the Clauss and Jacobsson methods by U-test
was observed (table 4).
Degradation study
Table 5 shows that the ﬁbrinogen potency ratio of the
test preparation determined by the Clauss method was
indicated at various stressed temperatures relative to
the reference stored at  20 C. It is suggested that the
test preparation is stable for one year at 20 Ca n dn o
Fresh human plasma
Cohn fraction I
Virus inactivation at 30˚C for 1 h
(treated with 1% (v/v) Tween 80 and 0.3% (v/v) TNBP)
Glycine precipitation 
(repeat three times)
Removal of plasminogen 
(lysine-Sepharose column)
Sterile filtration
Purified fibrinogen solution 
Lyophilization
(approximately 2.20 g l
–1)
Figure 1. Fibrinogen puriﬁcation procedure.
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M. Okuda et al. Proposed fibrinogen standard material with purified fibrinogenFigure 2. Comparison of calibration curves by Clauss’s method on Coagrex-800: , WHO standard (#98/612); , Test preparation.
Table 1. Precision between ﬁbrinogen standard materials on Coagrex-800.
Puriﬁed material Plasma material
Test preparation WHO (#98/612) Fib standard
TM
Within-run Between-day Within-run Between-day Within-run Between-day
Mean (gl
1) 2.20 2.21 2.21 2.20 2.32 2.31
SD 0.045 0.032 0.079 0.042 0.089 0.064
CV(%) 2.05 1.45 3.57 1.91 3.84 2.78
Mean of within-run and between-day reproducibility is expressed as ﬁbrinogen concentration (gl
1). The within-run was replicated
20 times and the between-day for ﬁve days.
Table 2. Precision comparisons of the test preparation among coagulation analysers.
Methods Mean (gl
1) SD CV (%)
Mann–Whitney
U-test
Manual method Jacobsson 2.22 0.097 4.37 *
Automated analyser Coagrex-700 2.21 0.038 1.72 n.s.
Coagrex-800 2.22 0.054 2.43 n.s.
CA-1500 2.17 0.051 2.35 n.s.
CA-7000 2.18 0.059 2.71 n.s.
Semi-automated analyser KC-4a micro 2.21 0.060 2.71 n.s.
n.s., No signiﬁcance versus mean of the Jacobsson method (*).
Mean is expressed as ﬁbrinogen concentration (gl
1) and was replicated 20 times. Fibrinogen concentrations were calculated by
WHO standard (#98/612). The Jacobsson method is a basic procedure for ﬁbrinogen standardization based on a gravimetric method.
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at 45 C for one month (table 5). The test prepara-
tion approximately predicted storage at 9 C for two years
(table 6).
Discussion
Fibrinogen is a heterogeneous plasma protein with three
pairs of polypeptide chains and is a crucial factor for
prothrombin time and activated partial thromboplastin
time assays. Many laboratories in Japan use Clauss’s
method for plasma ﬁbrinogen measurement on an auto-
mated coagulation analyser. However, its determination
is qualitative not qualitative. A very high variation in
its surveillance results was observed. A current issue in
ﬁbrinogen measurement was the poor precision reported
in various surveys [3,4]. The Haematology Subcommit-
tee of the Standardization Committee of the JSLM has
published a proposed standard method for the mea-
surement of ﬁbrinogen in plasma [5,6]. The present
authors reported a Japanese national ﬁbrinogen standard
with puriﬁed ﬁbrinogen for the purpose [7]. Thus, it is
suggested that a suitable standard might help to improve
the precision and accuracy of ﬁbrinogen measurement
in clinical laboratories [8].
After preparing the test preparation derived from puri-
ﬁed ﬁbrinogen, its measurement precision was compared
using ﬁve kinds of coagulation analysers. The test prepa-
ration showed a parallel calibration curve with the
WHO (#98/612) standard (ﬁgure 2) and superior preci-
sion to plasma materials for all within-run and between-
day measurements (table 1). The CV (<2.8%) for
within-run precision of the test preparation using
ﬁve instruments (Coagrex-700, Coagrex-800, CA-1500,
CA-7000, KC4a micro) produced excellent results
(table 2). The result measured by the Jacobsson method
based on a manual technique also showed satisfactory
precision as well as that of the Clauss method. No
signiﬁcance was observed for between-analyser preci-
sion (table 2). Furthermore, no discrepancy in the
ﬁbrinogen concentration among instruments with light
scattering detection (Coagrex and CA series), mechanical
detection (KC-4a) and the manual method (Jacobson)
was demonstrated. A homogeneous reaction between
the ﬁbrinogen substance and thrombin might have con-
tributed to good precision in the ﬁbrinogen material
when using puriﬁed ﬁbrinogen with a clear appearance
and no contaminants. It has also been reported that
plasma material consists of plasma proteins (antithrom-
bin, plasminogen, antiplasmin, coagulation factors) and
lipid contaminants (e.g. cholesterol, triglyceride, low-
and high-density lipoproteins) [9]. These results suggest
that the test preparation with a high purity aﬀects the
excellent precision for ﬁbrinogen measurement.
The degradation study was conducted to predict storage
time using stressed temperatures. When storage tempera-
ture is elevated, a potency of ﬁbrinogen by the Clauss
method was gradually decreased. Storage of the test
preparation at 45 C for two months or at 37 C for six
months resulted in the lyophilized material having good
reconstitutability and it gave suﬃciently clear clots on
the addition of thrombin (data not shown). No eﬀect was
observed following storage at 20 C and at lower tem-
peratures ( 20 and 4 C). Since it is predicted that the
maximum transport time during Japanese distribution
would be 1–2 weeks, the maximum transport tempera-
ture would be at ambient temperature (up to 30 C)
(table 6). The degradation data obtained thus far
indicate that the test preparation is a reliable and stable
material. It is proposed that a storage temperature is
routinely kept at <4 C for three years or at 9 C for two
years. Additional storage studies, however, are currently
being undertaken.
Table 5. Degradation stability of the test preparation.
Temperature (
C)
Storage (months)
01246
20 1.00 1.00 0.99 1.00 0.99
4 1.00 0.99 1.00 1.00 0.98
20 1.00 0.99 0.99 0.98 0.97
37 1.00 0.98 0.97 0.95 0.93
45 1.00 0.95 0.93 0.91 0.83
Means were calculated against the relative temperatures of the
ﬁbrinogen standard stored at 20
C. The bold ﬁgure indicates
the reference storage.
Table 6. Predicted storage of the test preparation.
Temperature
(
C)
Predicted
storage (years)
4 3.2
9 2.2
11 1.8
20 1.0
30 0.5
Predicted storage was calculated according to the Arrhenius
equation.
Table 4. Comparison of ﬁbrinogen concentration of the test
preparation.
Clauss
(C)
Jacobsson
(J)
C/J
(%)
Mann–Whitney
U-test
2.200.022 2.220.097 99.1% n.s.
n.s., No signiﬁcance versus Jacobsson (J).
Results of Clauss (C) and J were according to tables 2 and 3.
Mean is expressed as ﬁbrinogen concentration (gl
1) and was
replicated 20 times.
Table 3. Between-analyser precisions in the test preparation.
n Mean (gl
1) SD CV (%)
5 2.20 0.022 1.00
Mean is expressed as the ﬁbrinogen concentration (gl
1). Five
kinds of coagulation analysers (Coagrex-700, Coagrex-800, CA-
1500, CA-7000 and KC-4a micro) were used. The results were
calculated based on table 2.
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ﬁbrinogen standard for supply to Japanese medical
laboratories and manufacturers that displays high
precision and good transport stability using coagulation
analysers and it is hoped that the use of this standard as
a candidate material for plasma ﬁbrinogen measurement
in medical laboratories will help to improve the high
rate of inter- or between-laboratory variation observed
in Japanese surveillance on various automated or semi-
automated coagulation analysers.
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